STOCK TITAN

Alyeska discloses 5.93% Kindly MD (NAKA) ownership stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Alyeska Investment Group and related parties have disclosed a significant passive stake in Kindly MD, Inc. According to this Schedule 13G, Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh beneficially own 25,612,676 shares of Kindly MD common stock.

This position represents 5.93% of Kindly MD’s outstanding common shares, based on 431,653,091 shares outstanding as reported in the company’s Form 8-K filed on December 18, 2025. The filers certify that the shares were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of the company.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Alyeska Investment Group, L.P.
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:02/17/2026
Alyeska Fund GP, LLC
Signature:Jason Bragg
Name/Title:Jason Bragg | Chief Financial Officer
Date:02/17/2026
Anand Parekh
Signature:Anand Parekh
Name/Title:Anand Parekh | Self
Date:02/17/2026
Exhibit Information

The reporting persons are the beneficial owners of 25,612,676 common shares of the Issuer. The percentage of beneficial ownership is based on 431,653,091 shares of the registrant's common stock outstanding as reported on the Issuer's Form 8-K filed with the Securities and Exchange Commission on December 18, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

FAQ

What ownership stake in Kindly MD (NAKA) does Alyeska report in this Schedule 13G?

Alyeska and related reporting persons report beneficial ownership of 25,612,676 Kindly MD common shares, representing 5.93% of the company’s outstanding stock. This percentage is calculated using 431,653,091 shares outstanding, as disclosed in Kindly MD’s Form 8-K on December 18, 2025.

Who are the reporting persons on the Kindly MD (NAKA) Schedule 13G filing?

The reporting persons are Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh. All three share voting and dispositive power over 25,612,676 Kindly MD common shares, with no sole voting or dispositive authority reported for any of them individually.

Is Alyeska’s stake in Kindly MD (NAKA) reported as a passive investment?

Yes. The filing certifies the shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Kindly MD, consistent with a passive investment reported on Schedule 13G.

How is Alyeska’s 5.93% ownership in Kindly MD (NAKA) calculated?

The 5.93% figure is based on 25,612,676 shares beneficially owned divided by 431,653,091 outstanding shares of Kindly MD common stock. The outstanding share count comes from Kindly MD’s Form 8-K filed with the SEC on December 18, 2025.

What voting and dispositive powers does Alyeska report over Kindly MD (NAKA) shares?

The reporting persons disclose shared voting power over 25,612,676 shares and shared dispositive power over the same number of shares. They report no sole power to vote or to dispose of any Kindly MD common shares individually.

When did the ownership event triggering this Kindly MD (NAKA) Schedule 13G occur?

The date of the event requiring this Schedule 13G filing is December 31, 2025. This date marks when the reporting persons’ beneficial ownership position reached the level that triggered the obligation to report under SEC beneficial ownership rules.
Nakamoto Inc.

NASDAQ:NAKA

NAKA Rankings

NAKA Latest News

NAKA Latest SEC Filings

NAKA Stock Data

167.03M
408.93M
Medical Care Facilities
Finance Services
Link
United States
SALT LAKE CITY